HNN3.0
Register
Register
Register

Project cooperationUpdated on 16 January 2026

R&D services in bioprocess development and bioreactors for in vitro screening platforms

Co-development Architect at Antleron

Leuven, Belgium

About

From discovery to process development and CMC, Antleron’s smart scale-down model service combines custom, lab-scale, modular bioreactors with its Nexus-driven digital twin platform to predict, develop and optimize clinical-scale bioprocesses and manufacturing systems. Antleron’s CellGuide® fixed-bed upstream bioreactor platform completes its smart scale-down model offering by enabling improved quality, consistency and scalability from lab to patient for bespoke therapies.

Antleron also developed expertise and technology to facilitate high-throughput screening of materials and implants in a biological environment. The efficient and robust lab-scale testing platform is suitable for testing of a variety of parameters, timing and read-outs. It can be customized to accomodate different types of implants and materials.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine

Type

  • Partner seeks Consortium/Coordinator

Organisation

Antleron

Company (SME)

Leuven, Belgium

Similar opportunities

  • Project cooperation

    Multi & Single Use Bioreactors with Advanced Process Control

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)

    Esther Aguilar

    Senior Project Manager at TECNIC Bioprocess Solutions

    Riudarenes, Spain

  • Project cooperation

    HORIZON-HLTH-2026-01-TOOL-03

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Paola Castrillo

    Innovation Manager at BLUE SYNERGY

    Madrid, Spain

  • Project cooperation

    Upscaling cell production - from research to product

    • Partner seeks Consortium/Coordinator
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Wouter Beenker

    Project Manager / Scientist at Scinus Cell Expansion

    Zeist, Netherlands